American International Group’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-2,328
Closed -$242K 3155
2016
Q1
$242K Sell
2,328
-3,594
-61% -$375K ﹤0.01% 2600
2015
Q4
$752K Sell
5,922
-1,155
-16% -$141K ﹤0.01% 1688
2015
Q3
$808K Buy
7,077
+819
+13% +$108K ﹤0.01% 1618
2015
Q2
$844K Sell
6,258
-2,286
-27% -$304K ﹤0.01% 1721
2015
Q1
$1.11M Buy
8,544
+2,988
+54% +$375K ﹤0.01% 1527
2014
Q4
$641K Buy
5,556
+4,990
+882% +$562K ﹤0.01% 1921
2014
Q3
$59.9K Sell
566
-632
-53% -$63.9K ﹤0.01% 3895
2014
Q2
$114K Sell
1,198
-566
-32% -$50.7K ﹤0.01% 3469
2014
Q1
$160K Buy
1,764
+1
+0.1% +$97 ﹤0.01% 3032
2013
Q4
$156K Buy
1,763
+107
+6% +$8.95K ﹤0.01% 2982
2013
Q3
$137K Buy
1,656
+320
+24% +$25.1K ﹤0.01% 3065
2013
Q2
$91.5K Buy
+1,336
New +$93K ﹤0.01% 3210

Other funds holding BBH

American International Group's BBH Position: Q2 2016 in Review

American International Group sold out of VanEck Biotech ETF (BBH) in Q2 2016, closing a stake of 2,328 shares — an estimated $242K sold.

American International Group first reported a position in BBH in Q2 2013 and held it in 12 quarters. The position peaked at $1.11M in Q1 2015. 78 funds tracked by Wall St. Rank hold BBH as of Q2 2016.

  • American International Group reported no remaining VanEck Biotech ETF position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 2,328 VanEck Biotech ETF shares in Q2 2016, an estimated $242K.
  • American International Group first reported a position in VanEck Biotech ETF in Q2 2013 and held it in 12 quarters.
  • American International Group's VanEck Biotech ETF position peaked at $1.11M in Q1 2015.
  • 78 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.